SIRT1 and cancer: To that end, we measured the prevalence of R-loops in an isogenic system of cancer cells deficient or proficient in SIRT1, and in U2OS cells harboring an inactive SIRT1 mutant (H363Y, henceforth referred to as H3Y/Mut) [21].